1st-line Panitumumab plus FOLFIRI or FOLFOX for patients with RAS wildtype metastatic colorectal cancer in Germany – Interim results of the non-interventional study VALIDATE

5. November 2020

J. Uhlig, J. Potenberg, D. Semsek, P. Stübs, C. Fichter, A. Köhler, L. Müller, M. Reiser, H.U. Siebenbach, T. Göhler, L. Jacobasch, V. Kächele, B. Timm, K. Potthoff, N. Marschner, 2020

Download